Keyphrases
Clinical Outcomes
100%
T Cells
100%
Anticancer Immune Response
100%
Genetic Association
100%
Early-stage Lung Cancer
100%
T-cell Phenotype
100%
Single nucleotide Polymorphism
57%
Non-small Cell Lung Cancer (NSCLC)
42%
Genotype
28%
Genetic Variation
28%
Risk of Death
28%
Recurrence Risk
28%
High-risk Subjects
28%
Indoleamine 2,3-dioxygenase 1 (IDO1)
28%
Gene Expression
14%
Treatment Efficacy
14%
Recent Advances
14%
Chemotherapy
14%
Gene Expression Profile
14%
Tumor Immunity
14%
Meta-analysis
14%
Non-small Cell Lung Cancer Patients
14%
Quantitative Trait Loci Analysis
14%
Cumulative Effects
14%
Host Immune Response
14%
Immune-related Genes
14%
Degranulation
14%
Lung Cancer Prognosis
14%
Between-host
14%
Response Pathways
14%
Immune Genetic
14%
Impact Outcomes
14%
Lung Cancer Outcomes
14%
Cytotoxicity against Cancer Cells
14%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Immune Response
100%
Genetic Association
100%
Single-Nucleotide Polymorphism
44%
Gene Expression
22%
Immunity
22%
Genetic Variation
22%
Genetics
11%
Cancer Cell
11%
Cytotoxicity
11%
Degranulation
11%
Expression Quantitative Trait Loci
11%
Immune Response Gene
11%
GZMB
11%
Immunology and Microbiology
T Cell
100%
Immune Response
100%
Genetic Association
100%
Single Nucleotide Polymorphism
44%
Gene Expression
22%
Immunity
22%
Genetic Variation
22%
Cancer Cell
11%
Immunotherapy
11%
Cytotoxicity
11%
Degranulation
11%
Expression Quantitative Trait Loci
11%
Immune Response Gene
11%